Skip to Main Content
╳

Updates on our COVID-19 Research

Wistar Fights COVID-19

Wistar Science. Wistar Legacy.

Ways to Support

Recent Press Releases

View all ›

The Wistar Institute & Allevi Inc. Collaborate on 3D Bioprinting Project to Advance COVID-19 Research

Novel DNA-based Immunotherapy for Neutralizing Hepatitis B Virus infection 

Positive Results from Preclinical Testing Support Clinical Development of COVID-19 DNA Vaccine

Our Centers

Maureen and lab

Cancer Center

Wistar is a National Cancer Institute Cancer Center in basic research and has held this designation since 1972.
David and Ami_In the Lab1

Vaccine & Immunotherapy Center

Improving health around the globe by creating and advancing vaccines and immunotherapies.

Upcoming events

View all events ›

There are currently no events scheduled. Please check back later.

125 Years of Discovery

View full timeline ›
Stanley Plotkin

Rubella Vaccine

Stanley Plotkin, M.D., and Koprowski developed the vaccine of choice against rubella, also known as German measles. Rubella led to various birth defects including blindness, deafness and severe mental retardation as well as miscarriages and stillbirths across Europe and the U.S. in the 1960s.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today